Literature DB >> 34134113

Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.

Huei-Ying Chen1, Joseph F Bohlen2, Brady J Maher2,3,4.   

Abstract

Transcription factor 4 (TCF4, also known as ITF2 or E2-2) is a type I basic helix-loop-helix transcription factor. Autosomal dominant mutations in TCF4 cause Pitt-Hopkins syndrome (PTHS), a rare syndromic form of autism spectrum disorder. In this review, we provide an update on the progress regarding our understanding of TCF4 function at the molecular, cellular, physiological, and behavioral levels with a focus on phenotypes and therapeutic interventions. We examine upstream and downstream regulatory networks associated with TCF4 and discuss a range of in vitro and in vivo data with the aim of understanding emerging TCF4-specific mechanisms relevant for disease pathophysiology. In conclusion, we provide comments about exciting future avenues of research that may provide insights into potential new therapeutic targets for PTHS.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Basic helix-loop-helix; Neurodevelopmental disorder; Oligodendrocyte; Pitt-Hopkins syndrome; Transcription factor 4

Mesh:

Substances:

Year:  2021        PMID: 34134113      PMCID: PMC8440355          DOI: 10.1159/000516666

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   3.421


  57 in total

1.  Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.

Authors:  Marc Forrest; Ria M Chapman; A Michelle Doyle; Caroline L Tinsley; Adrian Waite; Derek J Blake
Journal:  Hum Mutat       Date:  2012-07-27       Impact factor: 4.878

2.  Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome.

Authors:  Peter Sparber; Alexandra Filatova; Inga Anisimova; Tatiana Markova; Viktoria Voinova; Alena Chuhrova; Vyacheslav Tabakov; Mikhail Skoblov
Journal:  Eur J Med Genet       Date:  2020-10-15       Impact factor: 2.708

3.  Transcription Factor 4 Safeguards Hippocampal Dentate Gyrus Development by Regulating Neural Progenitor Migration.

Authors:  Yafei Wang; Zhiheng Lu; Yilan Zhang; Yuqun Cai; Di Yun; Tianxiang Tang; Zheping Cai; Chunyang Wang; Yandong Zhang; Fang Fang; Zhengang Yang; Thomas Behnisch; Yunli Xie
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

4.  WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4.

Authors:  Krista M Hennig; Daniel M Fass; Wen-Ning Zhao; Steven D Sheridan; Ting Fu; Serkan Erdin; Alexei Stortchevoi; Diane Lucente; Jannine D Cody; David Sweetser; James F Gusella; Michael E Talkowski; Stephen J Haggarty
Journal:  Mol Neuropsychiatry       Date:  2017-07-14

5.  Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.

Authors:  Mari Sepp; Priit Pruunsild; Tõnis Timmusk
Journal:  Hum Mol Genet       Date:  2012-03-28       Impact factor: 6.150

6.  Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.

Authors:  Matthew D Rannals; Gregory R Hamersky; Stephanie Cerceo Page; Morganne N Campbell; Aaron Briley; Ryan A Gallo; BaDoi N Phan; Thomas M Hyde; Joel E Kleinman; Joo Heon Shin; Andrew E Jaffe; Daniel R Weinberger; Brady J Maher
Journal:  Neuron       Date:  2016-03-10       Impact factor: 17.173

7.  Knockdown of the schizophrenia susceptibility gene TCF4 alters gene expression and proliferation of progenitor cells from the developing human neocortex.

Authors:  Matthew J Hill; Richard Killick; Katherinne Navarrete; Aleksandra Maruszak; Gemma M McLaughlin; Brenda P Williams; Nicholas J Bray
Journal:  J Psychiatry Neurosci       Date:  2017-05       Impact factor: 6.186

8.  Mash1 regulates neurogenesis in the ventral telencephalon.

Authors:  S Casarosa; C Fode; F Guillemot
Journal:  Development       Date:  1999-02       Impact factor: 6.868

9.  Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations.

Authors:  Jill A Rosenfeld; Kathleen Leppig; Blake C Ballif; Heidi Thiese; Christine Erdie-Lalena; Erwati Bawle; Sujatha Sastry; J Edward Spence; Anne Bandholz; Urvashi Surti; Jonathan Zonana; Kory Keller; Wendy Meschino; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Genet Med       Date:  2009-11       Impact factor: 8.822

10.  Transcription factor Tcf4 is the preferred heterodimerization partner for Olig2 in oligodendrocytes and required for differentiation.

Authors:  Miriam Wedel; Franziska Fröb; Olga Elsesser; Marie-Theres Wittmann; D Chichung Lie; André Reis; Michael Wegner
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

View more
  1 in total

Review 1.  Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.

Authors:  Keri Martinowich; Debamitra Das; Srinidhi Rao Sripathy; Yishan Mai; Rakaia F Kenney; Brady J Maher
Journal:  Mol Psychiatry       Date:  2022-10-12       Impact factor: 13.437

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.